US$ 26.34
semaglutide uspi 3.0ML Weight Lose Pen Developed by Novo Nordisk Prescribing | Ozempic® (semaglutide) pill
Description
The PlexusDx Precision Peptide Genetic Test examines variants in GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313)genes that influence appetite regulation, fat metabolism, and food preference patterns

Genetic variants in GLP1R and GIPR receptors influence your personal response, which PlexusDx's Precision Peptide Genetic Test can identify before treatment begins

Excess weight is a significant risk factor for various health conditions, including heart disease, high blood pressure, and certain types of cancer

Am J Physiol Endocrinol Metab

doi: 10.1158/0008-5472.CAN-24-2982

Kupersmith MJ, Fraser CL, Morgenstern R, Miller NR, Levin LA, Jette N, et al
